Summary
The effect of the mixed-function oxidase inhibitor phenylimidazole (PI) and the amine oxidase inhibitors iproniazid (IPRO) and aminoacetonitrile (AAN) on the mutagenic activity of various carcinogens was determined in intrasanguineous host-mediated assays, using mice as hosts and E. coli 343/113 as an indicator of mutagenic activity. The carcinogenic compounds dimethyl-, diethyl-, methylethyl-, and diethanolnitrosamine (DMNA, DENA, MENA, and DELNA respectively) and 1,2-dimethylhydrazine (SDMH) were administered i.p. to mice pretreated or not with one of the inhibitors. After 4 h exposure to each of the carcinogens, E. coli cells recovered from the liver of non-pretreated mice showed considerable induction of VALr mutations; after pretreatment of the hosts with the three inhibitors, significant reduction of the amounts of induced mutants in vivo was observed. Particularly, PI proved a very efficient inhibitor of DENA, MENA, DELNA, and SDMH mutagenicity (93%–97% reduction), suggesting that these carcinogens are mainly activated by cytochrome P-450-dependent enzymes. However, since PI might also inhibit the NAD-mediated activation of DELNA by alcohol dehydrogenase (ADH), the present experiments do not rule out an additional role of ADH in the in vivo mutagenic activation of DELNA. AAN and IPRO were less and much less effective, respectively, in reducing the mutagenic activity of all compounds. Surprisingly, PI showed less inhibition of the mutagenic activity of DMNA (60% reduction), as compared to the other carcinogens; this indicates that metabolic routes other than the cytochrome P-450-dependent enzyme system may be important for the activation of DMNA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Airoldi L, Bonfanti M, Fanelli R, Bove B, Benfenati E, Gariboli P (1984) Identification of a nitrosamino aldehyde and a nitrosamino acid resulting from beta-oxidation of N-nitrosodiethanolamine. Chem Biol Interact 51:103–113
Arcos JC, Bryant GM, Venketesan N, Argus MF (1975) Repression of dimethylnitrosamine-demethylase by typical inducers of microsomal mixed function oxidase. Biochem Pharmacol 24:1544–1547
Ashby J (1983) The unique role of rodents in the detection of possible human carcinogens and mutagens. ICPEMC Working Paper 1/1. Mutat Res 115:177–213
Bartsch H, Malaveille C, Montesano R (1975a) Differential effect of phenobarbitone, pregnolone-16alpha-carbonitrile and aminoacetonitrile on dialkylnitrosamine metabolism and mutagenicity in vitro. Chem Biol Interact 10:377–382
Bartsch H, Malaveille C, Montesano R (1975b) In vitro metabolism and microsome-mediated mutagenicity of dialkylnitrosamines in rat, hamster and mouse tissues. Cancer Res 35:644–651
Bartsch H, Kuroki T, Roberfroid M, Malaveille C (1982) Metabolic activation systems in vitro for carcinogen/mutagen screening tests. In: de Serres FJ, Hollaender A (eds) Chemical mutagens, Vol 7. Plenum, New York, pp 95–161
Chau IY, Dagani D, Archer MC (1978) Kinetic studies on the hepatic microsomal metabolism of dimethylnitrosamine, diethylnitrosamine and methylethylnitrosamine. J Natl Cancer Inst 61:517–521
Cygan P, Greim H, Garro AJ, Hutterer F, Schaffner F, Popper H, Rosenthal O, Cooper DY (1973) Microsomal metabolism of dimethylnitrosamine and cytochrome P-450-dependency of its activation to a mutagen. Cancer Res 33:2983–2986
Druckrey H, Preussmann R, Ivankovic S, Schmähl D (1967a) Organotrope carcinogene Wirkungen bei 65 verschiedenen N-nitrosoverbindungen an BD-Ratten. Z Krebsforsch 69:103–201
Druckrey H, Preussmann R, Matzkies F, Ivankovic S (1967b) Selektive Erzeugung von Darmkrebs bei Ratten durch 1,2-Dimethylhydrazin. Naturwissenschaften 54:285–286
Eisenbrand G, Denkel E, Pool B (1984) Alcohol dehydrogenase as an activating enzyme for N-nitrosodiethanolamine (NDELA): in vitro activation of NDELA to a potent mutagen in Salmonella typhimurium. J Cancer Res Clin Oncol 108:76–80
Farelly JG, Stewart ML, Lijinski W (1984) The metabolism of nitroso-n-propylamine, nitrosodiallylamine and nitrosodiethanolamine. Carcinogenesis 5:1015–1019
Fiala ES (1977) Investigation into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine und azoxymethane. Cancer 40:2436–2445
Fiume L, Campadelli-Fiume G, Magee PN, Holsmann J (1970) Cellular injury and carcinogenesis. Inhibition of metabolism of dimethylnitrosoamine by aminoacetonitrile. Biochem J 120:601–605
Godoy HM, Diaz-Gomez MI, Castro JA (1978) Mechanism of dimethylnitrosamine metabolism and activation in rats. J Natl Cancer Inst 51:1285–1289
Greenawalt JW (1972) Localization of monoamine oxidase in rat liver mitochondria. Adv Biochem Psychopharmacol 5:207–226
Hadjilov D (1971) The inhibition of dimethylnitrosamine carcinogenesis in rat liver by aminoacetonitrile. Z Krebsforsch 76:91–92
Kerklaan P, Mohn G, Bouter S (1981) Comparison of the mutagenic activity of dialkylnitrosamines in animal-mediated and in vitro assays using an E. coli indicator. Carcinogenesis 2:909–914
Kerklaan PRM, Bouter S, Mohn GR (1984) Factors influencing the mutagenic activity of the colon carcinogen 1,2-dimethylhy-drazine in Salmonella typhimurium strain TA 1535 in vitro. Carcinogenesis 5:467–472
Lai DY, Arcos JC (1980) Dialkylnitrosamine bioactivation and carcinogenesis. Life Sci 27:2149–2165
Lake BG, Phillips JC, Heading CE, Gangolli SD, Llyod AG (1976) Studies on the in vitro metabolism of dimethylnitrosamine by rat liver. Toxicology 5:297–309
Lake BG, Phillips JC, Cottrell RC, Gangolli SD (1978) The possible involvement of a microsomal amine oxidase enzyme in hepatic dimethylnitrosamine degradation in vitro. In: Gorrod JW (ed) Biological oxidation of nitrogen. Elsevier/North-Holland Biomedical Press, pp 131–135
Lake GB, Collins MA, Harris RA, Phillips JC, Cottrell RC, Gangolli SD (1982) Studies on the metabolism of dimethylnitrosamine in vitro by rat liver preparations. I. Comparison with mixed-function enzymes. Xenobiotica 12:435–445
Lijinsky W, Reuber MD, Manning WB (1980) Potent carcinogenicity of nitrosodiethanolamine in rats. Nature 288:589–590
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Magee PN, Barnes JM (1956) The production of malignant primary hepatic tumors in the rat by feeding dimethylnitrosamine. Br J Cancer 10:114–122
Miller EC (1978) Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address. Cancer Res 38:1479–1496
Mohn G, Ellenberger J (1977) The use of Escherichia coli K12/343-113 (λ) as a multi-purpose indicator strain in various mutagenicity testing procedures. In: Kilbey BJ, Legator M, Nichols W, Ramel C (eds) Handbook of mutagenicity test procedures. Elsevier, Amsterdam, pp 95–118
Mohn G, Kerklaan P, de Knijff P, Bouter S (1981) Influence of phenotypic lag and division delay on apparent frequencies of induced mutations in Escherichia coli K-12. Mutat Res 91:419–425
Mohn GR, Kerklaan PRM, van Zeeland AA, Ellenberger J, Baan RA, Lohman PHM, Pons FW (1984) Methodologies for the determination of various genetic effects in permeable strains of E. coli K-12 differing in DNA repair capacity. Quantification of DNA adduct formation, experiments with organ homogenates and hepatocytes, and animal-mediated assays. Mutat Res 125:153–184
Moriya M, Ohta T, Watanabe K, Watanabe Y, Sugiyama F, Miayazawa T, Shirazu Y (1979) Inhibitors for the mutagenicities of colon carcinogens, 1,2-dimethylhydrazine and azoxymethane, in the host-mediated assay. Cancer Lett 9:325–330
Negishi T, Hayatsu H (1980) The pH-dependent response of Salmonella typhimurium TA100 to mutagenic N-nitrosamines. Mutat Res 79:223–230
Pegg AE (1978) Inhibition of the alkylation of nucleic acids and of the metabolism of 1,2-dimethylhydrazine by aminoacetonitrile. Chem Biol Interact 23:273–279
Pegg AE (1980) Metabolism of N-nitrosodimethylamine. In: Bartsch H, Tomatix L (eds) Molecular aspects of carcinogen screening tests. IARC Scientific Publications, no. 27, LARC, Lyon pp 3–22
Phillips JC, Bex C, Lake BG, Cottrell RC, Gangolli SD (1982) Inhibition of dimethylnitrosamine metabolism by some heterocyclic compounds and by substrates and inhibitors of monoamine oxidase in the rat. Cancer Res 42:3761–3765
Riceberg LJ, Simon M, Vunakis HV, Abeles RH (1975) Effects of aminoacetonitrile, an amine oxidase inhibitor, on mescaline metabolism in the rabbit. Biochem Pharmacol 24:199–125
Rowland R, Lake BG, Phillips JC, Gangolli SD (1980) Substrate and inhibitors of hepatic amine oxidase inhibit dimethylnitrosamine-induced mutagenesis in Salmonella typhimurium. Mutat Res 72:63–72
Wattenberg LW (1975) Inhibition of dimethylhydrazine-induced neoplasia of the large intestine by disulfiram. J Natl Cancer Inst 54:1005–1006
Wilkinson CF, Hetnarski K, Hicks LJ (1974) Substituted imidazoles as inhibitors of microsomal oxidation and insecticide synergists. Pestic Biochem Physiol 4:299–312
Zeller EA, Barsky J, Berman ER (1953) Amine oxidases. XI. Inhibition of monoamine oxidase by 1-isonicotyl-2-isopropylhydrazine. J Biol Chem 214:267–274
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kerklaan, P.R.M., Bouter, S., Zijlstra, J.A. et al. The effect of mixed-function oxidase and amine oxidase inhibitors on the activation of dialkylnitrosamines and 1,2-dimethylhydrazine to bacterial mutagens in mice. J Cancer Res Clin Oncol 111, 196–202 (1986). https://doi.org/10.1007/BF00389234
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00389234